Business
Currency:CAD
2024/FY
Stock NameRevenueRatio
Development, manufacture, license and sale of MDMA and MDXX class molecules1.04M100.00%
Product
No Data
Industry
No Data
Region
Currency:CAD
2024/FY
Stock NameRevenueRatio
Australia620.38K59.92%
License revenue224.34K21.67%
Consulting revenue88.25K8.52%
Canada69.96K6.76%
United States32.38K3.13%